May 22, 2026
Akari Therapeutics (AKTX) Stock Skyrockets 120% on Promising Cancer Drug Results
Akari Therapeutics (AKTX) stock soared 120% after-hours on preclinical data showing AKTX-101 works synergistically with adagrasib in pancreatic cancer models.
The post Akari Therapeutics (AKTX) Stock Skyrockets 120% on Promising Cancer Drug Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Micron (MU) Earnings and PCE Data: Critical Tests for Tech Stocks This Week
- 1 hour ago
Micron (MU) Stock Price Prediction: What to Expect Through 2031
- 1 hour ago
Five Key Stocks and Inflation Data Set to Drive Markets Next Week
- 4 hours ago
SpaceX (SPCX) Stock: 5-Year Price Forecast and Valuation Analysis
- 4 hours ago
OpenAI vs Anthropic IPO Showdown: Which AI Giant Makes the Smarter Investment?